SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001016504-11-000006
Filing Date
2011-05-17
Accepted
2011-05-17 16:59:23
Documents
26
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 inb10q_20110331.htm 10-Q 227289
2 inb001a.jpg GRAPHIC 56216
3 inb001b.jpg GRAPHIC 32048
4 inb002a.jpg GRAPHIC 32572
5 inb002b.jpg GRAPHIC 51088
6 inb003.jpg GRAPHIC 52486
7 inb004a.jpg GRAPHIC 80030
8 inb004b.jpg GRAPHIC 61774
9 inb005.jpg GRAPHIC 50138
10 inb006.jpg GRAPHIC 47423
11 inb007.jpg GRAPHIC 18006
12 inb008.jpg GRAPHIC 10135
13 inb009.jpg GRAPHIC 18283
14 inb010.jpg GRAPHIC 17172
15 inb011.jpg GRAPHIC 15670
16 inb012.jpg GRAPHIC 17187
17 inb013.jpg GRAPHIC 25154
18 inb014.jpg GRAPHIC 17498
19 inb015.jpg GRAPHIC 53082
20 inb016.jpg GRAPHIC 16197
21 inb017.jpg GRAPHIC 17668
22 inb018.jpg GRAPHIC 20450
23 exhibit31_1.htm EX-31.1 13545
24 exhibit31_2.htm EX-31.2 13296
25 exhibit32_1.htm EX-31.1 6103
26 exhibit32_2.htm EX-32.2 6164
  Complete submission text file 0001016504-11-000006.txt   1248567
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 11852248
SIC: 2834 Pharmaceutical Preparations